✦ LIBER ✦

Dopamine D1 receptor antagonism in schizophrenia: Is there reduced risk of extrapyramidal side-effects?

✍ Scribed by Jarmo Hietala; Jaakko Lappalainen; Markku Koulu; Erkka Syvälahti

Book ID: 119112552
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 713 KB
Volume: 11
Category: Article
ISSN: 0165-6147
DOI: 10.1016/0165-6147(90)90147-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serotonin and dopamine receptor gene pol

Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients

✍ Arzu Gunes; Maria Gabriella Scordo; Peeter Jaanson; Marja-Liisa Dahl 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 179 KB

No relationship betweenTaq1 a polymorphi

No relationship betweenTaq1 a polymorphism of dopamine D2 receptor gene and extrapyramidal adverse effects of selective dopamine D2 antagonists, bromperidol, and nemonapride in schizophrenia: A preliminary study

✍ Mihara, Kazuo ;Suzuki, Akihito ;Kondo, Tsuyoshi ;Nagashima, Udai ;Ono, Shingo ;O 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

The relationship between Taq1 A polymorphism of dopamine D 2 receptor (DRD 2 ) gene and extrapyramidal adverse effects of bromperidol and nemonapride, which are both antipsychotic drugs with selective and potent DRD 2 antagonistic property, was investigated in Japanese schizophrenic inpatients. Twen

D2 dopamine receptor upregulation is ass

D2 dopamine receptor upregulation is associated with poor treatment response and extrapyramidal side effects in schizophrenia: A follow-up study with 123I-IBZM spect in the drug-naive state and after neuroleptic treatment

✍ J. Schroder; B. Bubeck; S. Silvestri; M. Karr; S. Demisch; H. Sauer 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 90 KB